US Broker Ratings

agilon health, inc. (AGL): Investor Outlook Suggests 82.56% Potential Upside Amidst Challenging Metrics

agilon health, inc. (NYSE: AGL) emerges as a compelling yet challenging prospect for investors in the healthcare sector. Known for its innovative platform that revolutionizes senior healthcare through primary care..

U.S. Physical Therapy, Inc. (USPH): Investor Outlook with a Potential 33.57% Upside

U.S. Physical Therapy, Inc. (USPH) stands as a compelling opportunity for investors eyeing the healthcare sector, particularly within the medical care facilities industry. With its roots dating back to 1990..

MiMedx Group, Inc (MDXG) Stock Analysis: Exploring the 85% Upside Potential in Biotechnology

MiMedx Group, Inc (NASDAQ: MDXG) has become a notable name within the healthcare sector, specifically in the biotechnology industry. Headquartered in Marietta, Georgia, and founded in 2006, this U.S.-based company..

Centessa Pharmaceuticals (CNTA) Stock Analysis: A High-Reward Prospect with 131% Potential Upside

Centessa Pharmaceuticals plc (NASDAQ: CNTA) has captured the attention of investors with an impressive potential upside of 131.28%, making it a compelling prospect in the biotechnology sector. This UK-based company,..

Progyny, Inc. (PGNY) Investor Outlook: Exploring a 22.38% Upside Potential in the Fertility Benefits Sector

Progyny, Inc. (NASDAQ: PGNY), a prominent player in the healthcare sector, specifically within healthcare plans, is making waves with its unique approach to fertility and family-building benefits. With a market..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Uncovering a Potential 179% Upside in the Biotech Sector

Celldex Therapeutics, Inc. (NASDAQ: CLDX) is making waves in the biotechnology sector, capturing the attention of investors with its promising pipeline and significant potential upside. With a market capitalization of..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: 40% Upside Potential Amidst Solid Revenue Growth

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH), a key player in the healthcare sector, is drawing investor attention with a potential upside of 40.37% based on its current stock price and..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring a 207% Potential Upside in Revolutionary Muscle Disorder Therapies

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) has emerged as a notable player in the biopharmaceutical sector, focusing on innovative treatments for muscle disorders. With a market capitalization of $1.33 billion, this..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a Potential 197.89% Upside with Strong Buy Ratings

Opko Health, Inc. (NASDAQ: OPK) stands prominently in the healthcare sector, specifically within the diagnostics and research industry. Despite its current challenges, including a significant decline in revenue, the company..

Integra LifeSciences Holdings C (IART): Investor Outlook on a Stock with 26.47% Potential Upside

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a prominent player in the medical devices sector, presents an intriguing opportunity for investors interested in the healthcare industry. Based in Princeton, New Jersey,..

Harrow, Inc. (HROW): Analyst Ratings Suggest 81% Upside Potential in the Healthcare Sector

Harrow, Inc. (NASDAQ: HROW) stands out as a compelling opportunity within the healthcare sector, specifically in the niche of ophthalmic pharmaceuticals. With its roots dating back to 1998 and a..

MannKind Corporation (MNKD): Analyst Consensus Suggests a Compelling 166.34% Upside Potential

MannKind Corporation (MNKD), a biopharmaceutical company specializing in treatments for endocrine and orphan lung diseases, is generating considerable attention in the healthcare investment sector. With a market capitalization of $1.08..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Steady Revenue Growth with Modest Upside Potential

Healthcare Services Group, Inc. (NASDAQ: HCSG), a prominent player in the healthcare sector, provides essential management and operational services to medical care facilities across the United States. With a market..

Galapagos NV (GLPG) Stock Analysis: Navigating the Biotech Sector with Strategic Partnerships

Galapagos NV (NASDAQ: GLPG), a prominent player in the biotechnology sector, is making waves with its innovative approach to drug development, particularly in the fields of oncology and immunology. Headquartered..

AdaptHealth Corp. (AHCO) Stock Analysis: A 39% Potential Upside in the Healthcare Sector

AdaptHealth Corp. (NASDAQ: AHCO), a key player in the healthcare sector specializing in medical devices, presents a compelling investment opportunity with a potential upside of 39.19% based on the average..

Evotec SE (EVO) Stock Analysis: Navigating a 46% Upside Potential in the Biotech Arena

For investors with an eye on the dynamic healthcare sector, Evotec SE (EVO) presents an intriguing prospect. As a prominent player in the drug discovery and development industry, Evotec’s global..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: A 167.92% Upside Potential in Biotech

For investors navigating the dynamic landscape of the biotechnology sector, Mineralys Therapeutics, Inc. (NASDAQ: MLYS) presents an intriguing opportunity, with analyst ratings suggesting a potential upside of 167.92%. As a..

The Pennant Group, Inc. (PNTG) Stock Analysis: A 30% Potential Upside in Healthcare Services

For investors seeking opportunities in the healthcare sector, The Pennant Group, Inc. (NASDAQ: PNTG) presents a compelling case with its promising growth prospects and strong analyst ratings. Specializing in home..

Establishment Labs Holdings Inc (ESTA): Investor Outlook on a High-Potential Medical Device Innovator

Establishment Labs Holdings Inc (NASDAQ: ESTA) stands out as a significant player in the healthcare sector, particularly within the medical devices industry. Headquartered in Alajuela, Costa Rica, this company has..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Unlocking 97.87% Potential Upside with Cutting-Edge Therapeutics

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a key player in the biotechnology sector, is making waves with its innovative approach to treating rare diseases. Headquartered in Durham, North Carolina, this company..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds